Skip to main content
VCbacked
Log inGet Started

Sentry Health

Louisville, United States

Sentry Health integrates technology with guidance from Nurse Advocates steering members to higher quality and more affordable care.

$1.0M raised
Nov 2022
Venture - Series Unknown
Health CareService IndustryWellness

Top Investors

OCA VenturesKeyhorse CapitalCommonwealth Seed CapitalLunsford CapitalDoug Cobb

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Sentry Health

How much funding has Sentry Health raised?
Sentry Health has raised $1.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in November 2022.
Who are Sentry Health's investors?
Sentry Health's investors include OCA Ventures, Keyhorse Capital, Commonwealth Seed Capital, Lunsford Capital, Doug Cobb.
Where is Sentry Health headquartered?
Sentry Health is headquartered in Louisville, United States.
What does Sentry Health do?
Sentry Health integrates technology with guidance from Nurse Advocates steering members to higher quality and more affordable care.
What stage is Sentry Health at?
Sentry Health is at the Venture - Series Unknown stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Sentry Health — Funding & Investors." VCBacked, November 29, 2022, https://www.vcbacked.co/company/sentry-health. Accessed July 2, 2026.
APA
VCBacked. (2022). Sentry Health — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/sentry-health
Wikipedia (cite web)
{{cite web |title=Sentry Health — Funding & Investors |url=https://www.vcbacked.co/company/sentry-health |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Health Care

View all
Oryl Photonics
Lausanne
Allterum Therapeutics
Houston$1.0M
OncoRevive
Brunswick$119K
Rapport Therapeutics
Boston$250.0M
YLAH
Bern$589K
Novostia
Epalinges$6.6M